Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
Go back to Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research| (NYSE: MANE) | Delayed: 102.79 +8.92 (9.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.87 | 52 Week High | $ | |||
| Open | $96.03 | 52 Week Low | $ | |||
| Day High | $106.00 | P/E | N/A | |||
| Day Low | $95.93 | EPS | $ | |||
| Volume | 896,756 | |||||

